Importance: General practitioners (GPs) sometimes initiate a treatment despite not expecting it to improve patients' symptoms by any physiological mechanism. These essentially placebo treatments are ethically controversial, and their frequency is unclear. They involve risks for patients, but to estimate these, more data are needed. Objective: To develop a more precise overview of the rate at which GPs prescribe...
Funding Information: This study received a European General Practice Research Network (EGPRN) Grant (www.egprn.org) Issue no: 2019/003. Publisher Copyright: Copyright © 2022 Dibao-Dina, Oger, Foley, Torzsa, Lazic, Kreitmayer Peštiae, Adler, Kareli, Mallen, Heaster, Dumitra, Kurpas, Viegas, Giezendanner, Tkachenko, De Lepeleire, Falanga, Missiou, Jennings and Petrazzuoli.; Background: Intermediate care is often ...
Funding: The work of Katharina Tabea Jungo was supported by the Swiss National Science Foundation (SNSF) (NFP 407440_167465, PI Prof. Streit) and the work of Zsofia Rozsnyai by the Swiss Society of General Internal Medicine (SGAIM) Foundation (PI Prof. Streit). The SGAIM Foundation reviewed the study protocol but did not give us feedback or help usplan, conduct, interpret results, or write this manuscript. The ...